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Abstract
Background: Brucellosis is a disease with significant public and economic implications but strategies for controlling this disease 
remain problematic.
Objectives: This study sought to determine the sero-prevalence of  brucellosis in prolonged fever patients and to identify mod-
ifiable risk factors for the infection in humans in post conflict Northern Uganda.
Methods: The study employed a cross-sectional method among prolonged fever patients who had visited selected health facili-
ties in the study districts in Northern Uganda. Sero-prevalence of  brucellosis was calculated for i-ELISA IgG/IgM. A structured 
questionnaire was used to obtain data on possible risk factors for brucellosis. Associations between sero-prevalence and risk 
factors were measured using the Odds Ratio.
Results: Brucellosis was confirmed in 18.7% of  the 251 patients that tested positive for the disease, with the rapid Brucella Plate 
Agglutination Test, and ages 10-84 years (median age 47+0.86). Sex (p = 0.001; OR 3.79; 95% CI 1.75 - 8.24), rearing livestock 
(p < 0.005; OR 8.44; 95% CI 2.84-25.03) and consumption of  unpasteurised milk (p = 0.023; OR 2.57; 95% CI 1.14-5.80) were 
factors associated with brucellosis.
Conclusion: Control of  brucellosis in animals, training and sensitisation of  the community on brucellosis is needed to stimulate 
action on human brucellosis control.
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Brucellosis is a widespread zoonosis of  both public 
health and economic concern1–3. The global burden of  
human brucellosis remains enormous with more than 
500,000 new infections occurring annually worldwide4. 
Brucellosis is caused by organisms of  genus Brucella with 
six pathogenic species of  which four are known to cause 
human disease5. B. melitensis cause the most severe hu-
man disease, followed by B. suis, B. abortus and B. canis6. 
In humans brucellosis is transmitted by direct or indirect 
contact with infected animals and their products7. Inhala-
tion of  infectious aerosols and ingestion of  raw milk or 
unpasteurized dairy products or meat from an infected 
animal is the most frequent route of  infection8,9. Major 
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symptoms for brucellosis in humans include; undulant 
fever, weight loss, back pain, fatigue and night sweats1.
Diagnosis of  brucellosis is impossible without laborato-
ry confirmation involving a combination of  methods10. 
Blood culture for Brucellae isolation remains the gold stan-
dard11 but may not provide a positive result for all pa-
tients12. Nucleic acid amplification can provide rapid de-
tection and confirmation of  Brucella13 but standardization 
of   extraction methods, infrastructure, equipment and 
expertise are still lacking6. Bacteriological and genomic 
limitations make serology the most practical and useful 
tool for brucellosis diagnosis11. The serological tests like 
Rose Bengal Plate Agglutination Test (RBPT), standard 
tube agglutination test (STAT), Enzyme Linked Immu-
no-Sorbent Assay (ELISA) and fluorescence polarization 
assay (FPA) among others have been applied in human 
brucellosis diagnosis11,13,14. However, STAT remains the 
most popular serological test used14 and titres of  1:160 
and above are considered diagnostic13. Nevertheless, 
STAT has limitations making ELISA to be most accept-
able for diagnosing human brucellosis11,15,16. Mantur and 
others11 found ELISA to be more sensitive than STAT 
in detecting brucellosis in both acute and chronic cases 
while sensitivity and specificity of  ELISA was reported 
to be 71.3% and 100% respectively. Araj and others15 re-
ported sensitivities of  100% and 91% for IgM and IgG 
ELISAs, respectively, and a specificity of  100% for both 
assays. In addition, Asaad and other workers16 reported 
sensitivities of  ELISA IgM and IgG to be 85.2% and 
96.3%,respectively and specificity of  100% for each..
 
Human brucellosis occurs widely in Uganda8,17,18. A recent 
study carried out in Gulu district in Northern Uganda re-
ported individual animal and herd level sero-prevalence 
of  bovine brucellosis to be 6% and 19%, respectively. 
Restocking and communal grazing were the major risk 
factors associated with the disease19. Northern Uganda is 
under rehabilitation with promotion of  livestock rearing 
and re-stocking. To date, no study has described human 
brucellosis in post conflict Northern Uganda, a region 
that witnessed a total breakdown in socio-economic infra-
structure, governance and services. The aim of  this study 
was to estimate the sero-prevalence of  human brucellosis 
in prolonged fever patients and identify modifiable risk 
factors for the infection in post-conflict Northern Ugan-
da. This study considered ELISA IgG/IgM which is re-
ported as the most specific serology test against SAT.
Methods
Ethics and consent to participate statement
Ethical approval was obtained from Gulu University Re-
search Council (Ref  No: GU/IRC/02/07/13) and the 
Uganda National Council of  Science and Technology 
(UNCST) Reference No: HS 1442. Written consent/as-
sent was sought from all individuals before enrolment.
 
The study was carried out in post-conflict areas of  North-
ern Uganda, in the districts of  Apac, Gulu, Lira and Pader 
covering up to nine percent of  the country's 236,040 Km2 
area size.
 
Study design and enrolment of  study patients
A cross-sectional study was conducted from March 2014 
to February 2015. Study patients were selected from 17 
out of  the 244 public and private health facilities in the 
study area20–23. The health facilities were purposively se-
lected basing on capacity to test for brucellosis and will-
ingness to participate in the study. The study targeted pa-
tients with fever, headache, joint pain, malaise, backache, 
fatigue and loss of  appetite visiting study health facilities. 
Medical personnel in the out patient department (OPD) 
identified suspects and tested them with the rapid Brucel-
la Plate Agglutination Test (BPAT). The sample size for 
study subjects was calculated using the formula for cross 
sectional survey as described before24 at 5% desired pre-
cision and 95% confidence interval with prevalence of  
human brucellosis in Uganda estimated at 18%8.
Laboratory investigation
To determine the sero-prevalence of  brucellosis in pro-
longed fever patients, STAT 1: 160 was used as the stan-
dard serological test against SAT 1: 320, iELISA IgG, 
iELISA IgM and iELISA IgG/IgM. Only BPAT positive 
samples from consented subjects were further investi-
gated. All subjects were briefed on the objectives of  the 
study, and signed a consent form. Cephalic vein blood 
was collected into sterile silicon-coated tubes without an-
ticoagulant for serum harvesting after 24 hours at room 
temperature. The serum was transported on ice to Mak-
erere University, College of  Veterinary Medicine, Animal 
Resources and Biosecurity (CoVAB) and kept at -200C. 
Samples were analysed using STAT (Remel kit, Europe) 
and i-ELISA (Vircell S.L, Santa Fe, and Granada, Spain) 
according to the manufacturers’ guidelines. To improve 
sensitivity, results for i-ELISA, were interpreted in paral-
lel, with any IgG or IgM positive test reported as positive 
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for i-ELISA as described previously17. A structured ques-
tionnaire was used to obtain data on possible risk factors 
for human brucellosis. Information collected from study 
subjects included age, gender, district of  origin, education 
level, rearing livestock, knowledge on brucellosis trans-
mission and practice of  consumption of  unpasteurized 
milk/milk products.
Statistical analysis
Sero-prevalence of  brucellosis in humans was calculated 
for both STAT and i-ELISA (IgG and IgM). Associations 
between sero-prevalence of  human brucellosis and mod-
ifiable risk factors were assessed with a Chi-square test 
and Odds Ratio at 95% confidence interval using SPSS, 
(SPSS Inc. Chicago, USA Version 16.0). Variables with 
p ≤ 0.1 at univariable analysis were included in a multi-
variable logistic regression model. The backward selec-
tion procedure was used to identify factors for the final 
models. Goodness of  fit for the final model was assessed 
using Hosmer and Lemeshow goodness of  fit test.
 
Results
A total of  251 prolonged fever patients aged 10-84 years 




Figure 1: Distribution of study patients by gender and age group 
Up to 207 study subjects were from government and 44 
from private health facilities. All serological tests showed 
significant (p<0.05) differences in brucellosis sero-posi-
tivity between health facilities, sex and keeping livestock. 
In addition brucellosis sero-positivity differed significant-
ly (p<0.05) with consumption of  milk and milk products 
basing on STAT 1:160, 1:320 and i-ELISA IgM, but did 
not differ basing on i-ELISA IgG. There was no differ-
ence in sero-positivity with education level (p>0.05) bas-
ing on all the four serological tests (Table 1). 
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Table 1:  Sero-prevalence of brucella among prolonged fever patients 
 
   Test Results (%,p-value), n=251 
Variable Category Frequency STAT 1:160 STAT1:320 i-ELISA IgG i-ELISA 
IgM 
Health facility Government 207 32.7(0.000)* 17.5(0.026)* 12.7(0.005)* 10.8(0.039)* 
Private 44 2.0 1.2 0.0 0.4 
Gender    Male 117 19.9(0.012)* 11.2 (0.048)* 10.8(0.000)* 8.4(0.001)* 
Female 134 14.7   7.5 1.9 2.8 
Age category of 
patients 
Children 8 0.8(0.887) 0.0(0.0507) 0.0(0.722) 0.0(0.361) 
Youth 188 26.3 14.3 9.6 7.6 
Adult 41 6.0 3.6 2.4 2.4 
Elderly 14 1.6 0.8 0.8 1.2 
Educational ≤Primary 152 22.7(0.242) 11.2(0.878) 7.6(0.883) 8.0(0.212) 
level > Primary 99 12.0 7.5 5.1 3.2 
Keep livestock Yes 145 29.9(0.000)* 16.3(0.000)* 11.1(0.000)* 10.4(0.000)* 
No 106 4.8 2.4 1.6 0.8 
Knowledge 
Transmission 
No 231 31.5(0.601) 16.7(0.453) 11.6(0.753) 9.2(0.040)* 





No 151 27.1(0.000)* 17.1(0.000)* 9.6(0.066) 9.2(0.012)* 
Yes 100 7.6 1.6 3.1 2.0 
* 5% level of significance 
Basing on the parallel interpretation of  either positive 
i-ELISA IgG or IgM or both tests, brucellosis sero-prev-
alence differed significantly (p<0.05) with gender, rearing 
livestock and consumption of  unpasteurised milk/milk 
products (Table 2). 
Table 2. Relationship between the hypothesised risk factors for human  
brucellosis and sero-positivity based on i-ELISA IgG/IgM. 
 
Variable Category 
% test positive 
(n=251) χ2 df p-value 
Gender Male 14.3 20.89 1 <0.005* 
 
Female 4.4 
   Age group < 30years 5.2 3.15 1 0.076 
 
> 30 years 13.5 
   Education level ≤Primary 12.0 0.26 1 0.611 
 
> Primary 6.7 
   Keep livestock Yes 17.1 26.95 1 <0.005* 
 
No 1.6 
   Knowledge on Not Know 14.3 1.82 1 0.178 
Transmission Knowledgeable 3.4 
   Consume milk Unpasteurised 14.7 8.32 1 0.004* 
and milk products Pasteurised 4.0 
             * Significant at 5% level 
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Gender (OR 3.79; 95% CI: 1.75-8.24), livestock rear-
ing (OR 8.44; 95% CI: 2.84-25.03) and consumption of  
unpasteurised milk (OR 2.57; 95% CI: 1.14-5.80) were 
significantly associated with brucellosis. The model ex-
plained 30.9% (NagelkerkeoR2) of  the variance in bru-
cellosis sero-prevalence and correctly classified 83.3% of  
the cases. The Odds of  being brucella positive in males 
with prolonged fever were four times the Odds in females. 
Livestock rearing was highly associated with brucella se-
ro-positivity and consumption of  unpasteurised milk and 
milk products increased the likelihood of  testing brucella 
sero-positive (Table 3).
Table 3.  Multivariable logistic regression of factors associated with human 
brucellosis in post-conflict northern Uganda 
 
    % Sero- Odds   
Variable Category positivity (n=251) Ratios(95%CI) p-values   
Gender Male 14.3 3.79(1.75-8.24) 0.001*   
 Female               4.4               
 
  
Age group < 30 years 5.2 1.73 (0.80-3.75) 0.164   
 > 30 years 13.5  
 
  
Keep livestock Yes 17.1 8.44(2.84-25.03) 0.005*   
 No 1.6  
 
  
Consumption of Unpasteurised 14.7 2.57(1.14-5.80) 0.023*   
Milk/milk products Pasteurised 4.0       
* 5% level of significance 
  
Discussion
This is the first study to document the sero-prevalence of  
human brucellosis among patients with prolonged fever 
in Northern Uganda. The study showed sero-prevalence 
of  human brucellosis in Northern Uganda to be 18.7% 
with i- ELISA and 34.7% with STAT (1:160). However, 
sero-positivity with STAT titres (1>1:320) was 18.7%, an 
indication of  active infection. This is not surprising since 
study subjects had come to seek medical attention with 
symptoms relating to brucellosis. This finding is compa-
rable to a recent study17 which reported STAT sero-prev-
alence results not to be different (p<0.05) from that 
for c-ELISA. Findings here support the use of  ELISA 
tests for confirming brucellosis in low-income countries 
where brucellosis is endemic. This study showed men to 
be four times likely to test positive for brucellosis than 
women. In the current study, milking and grazing animals 
is a man's role thus men are more in contact with ani-
mals than women. This finding is supported by reports 
of  epidemiological studies in other parts of  the world 
where human brucellosis is considered an occupational 
disease25. In addition, reports show no sex-wise discrimi-
nation of  brucellosis infection between male and female 
as both have equal susceptibility if  provided with expo-
sure to potential risk factors26. Nevertheless, the current 
study contradicts studies elsewhere which reported high 
prevalence of  brucellosis among females than males25,27.
This study clearly shows livestock rearing (p<0.005) to 
be strongly associated with human brucellosis. Generally, 
livestock harbour brucellosis in a sub-clinical state and 
farm families are at high risk of  exposure to the disease 
through contact with fluids of  affected livestock or con-
sumption of  their unpasteurized products. This study is 
in agreement with Corbel6 who pointed out that when 
animals are kept in close proximity to human habitat, the 
practice can result in brucella infection as people are in 
constant contact with infective materials. This study has 
also shown brucellosis sero-positivity to be highly associ-
ated with consumption of  unpasteurised milk/milk prod-
ucts. This finding parallels another study28 which report-
ed that significantly (p<0.02) more sero-positive humans 
with a history of  raw milk. This calls for increased aware-
ness among the communities in post-conflict Northern 
Uganda about the dangers associated with drinking raw 
milk, among others. Since this study dealt with only sus-
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pected brucellosis patients and did not cover all health 
facilities, results need to be interpreted cautiously. How-
ever, the study has provided important information to 
support brucellosis control programs.
 
Conclusion and recommendations
Findings in this study show clearly that the sero-prev-
alence of  human brucellosis among patients with pro-
longed fever is high (18.7%). Rearing livestock and con-
sumption of  unpasteurised milk/milk products were 
factors associated with brucellosis. Strategies to control 
animal brucellosis and raising awareness about the con-
sumption of  unpasteurised milk and milk products are 
necessary to reduce the incidence of  human infection in 
Northern Uganda. Innovative methods to sensitize the 
community on brucellosis and cost effective methods to 
control animal brucellosis are recommended.
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